RESUMO
Osteoporosis and associated fractures are an increasingly prevalent concern with an ageing population. This study reports testing of IBEX Bone Health (IBEX BH) software, applied following acquisition of forearm radiographs. IBEX Bone Health analyses the radiograph to measure areal bone mineral density (aBMD) at the examination site. A non-randomized cross-sectional study design was performed involving 261 (254 after exclusions) participants (112/142 m/f; mean age 70.8 years (SD+/-9.0); 53 with osteoporosis). They underwent posterior-anterior distal forearm radiographs; dual X-ray absorptiometry (DXA) of the wrists, hips, and lumbar spine; and questionnaires exploring clinical risk factors. IBEX Bone Health automatically identifies regions of interest (ROI) at the ultra-distal (UD) and distal third (TD) regions of the radius. Analysis investigated area under the receiver operating characteristics curve performance of IBEX BH for prediction of (i) osteoporosis (based on clinical reporting of the hip and spine DXA) and (ii) treatment recommendations by Fracture Risk Assessment Tool (FRAX) inclusive of neck of femur (NoF) areal bone mineral density (aBMD) results following National Osteoporosis Guideline Group (NOGG) guidelines. Area under the receiver operating characteristics curve for osteoporosis prediction at the UD and TD ROIs were 0.86 (99% confidence interval (CI) [0.80, 0.91]) and 0.81 (99% CI [0.75, 0.88]), respectively. Area under the receiver operating characteristics curve for treatment recommendation using FRAX inclusive of NoF aBMD at the UD and TD ROIs were 0.95 (99% CI [0.91, 1.00]) and 0.97 (99% CI [0.93,1.00]), respectively. With a matched sensitivity to FRAX (without NoF aBMD) 0.93 (99% CI [0.78, 0.99]), IBEX BH predicted at the UD and TD ROIs recommended treatment outcomes by NOGG guidelines using FRAX (with NoF aBMD) with specificity 0.89 (99% CI 0.83, 0.94]) and 0.93 (99% CI [0.87, 0.97]), respectively. This is compared with 0.60 (99% CI [0.51, 0.69]) for FRAX (without NoF aBMD). Results demonstrate the potential clinical utility of IBEX BH as an opportunistic screening tool.
RESUMO
OBJECTIVE: A new method for fitting diffusion-weighted magnetic resonance imaging (DW-MRI) data composed of an unknown number of multi-exponential components is presented and evaluated. METHODS: The auto-regressive discrete acquisition points transformation (ADAPT) method is an adaption of the auto-regressive moving average system, which allows for the modeling of multi-exponential data and enables the estimation of the number of exponential components without prior assumptions. ADAPT was evaluated on simulated DW-MRI data. The optimum ADAPT fit was then applied to human brain DWI data and the correlation between the ADAPT coefficients and the parameters of the commonly used bi-exponential intravoxel incoherent motion (IVIM) method were investigated. RESULTS: The ADAPT method can correctly identify the number of components and model the exponential data. The ADAPT coefficients were found to have strong correlations with the IVIM parameters. ADAPT(1,1)-ß0 correlated with IVIM-D: ρ = 0.708, P < 0.001. ADAPT(1,1)-α1 correlated with IVIM-f: ρ = 0.667, P < 0.001. ADAPT(1,1)-ß1 correlated with IVIM-D*: ρ = 0.741, P < 0.001). CONCLUSION: ADAPT provides a method that can identify the number of exponential components in DWI data without prior assumptions, and determine potential complex diffusion biomarkers. SIGNIFICANCE: ADAPT has the potential to provide a generalized fitting method for discrete multi-exponential data, and determine meaningful coefficients without prior information.
